Mushroom power: could AHCC keep your toddler Cold-Free?
NCT ID NCT07479394
First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 1 time
Summary
This study tests whether a daily supplement called AHCC, made from shiitake mushrooms, can reduce the number of respiratory infections (like colds) in children aged 2 to 4. Sixty children in daycare will receive either AHCC or a placebo for three months. Researchers will track fevers and measure immune markers to see if the supplement boosts immunity.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY TRACT INFECTIONS (RTI) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New surveillance study aims to spot respiratory outbreaks before they spread
- Massive dutch study reveals true toll of respiratory infections on hospitals
- A simple breath test could spot lung infections in minutes
- Could a Mitochondria-Boosting supplement beat multivitamins for preventing colds?
- New study tests Under-the-Tongue tablet to ward off Kids' winter colds
- France launches massive virus surveillance in GP clinics